Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Treasury Shares (2018 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Treasury Shares for 12 consecutive years, with $4.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares fell 64.69% to $4.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.3 million, a 64.69% decrease, with the full-year FY2024 number at $1.6 million, down 53.45% from a year prior.
  • Treasury Shares was $4.3 million for Q3 2025 at Xtant Medical Holdings, down from $5.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $12.2 million in Q3 2024 to a low of $2.3 million in Q1 2021.
  • A 5-year average of $4.2 million and a median of $3.6 million in 2022 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: surged 209.19% in 2021, then tumbled 64.69% in 2025.
  • Xtant Medical Holdings' Treasury Shares stood at $3.0 million in 2021, then rose by 21.63% to $3.6 million in 2022, then fell by 2.43% to $3.5 million in 2023, then surged by 54.78% to $5.5 million in 2024, then decreased by 20.8% to $4.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Treasury Shares are $4.3 million (Q3 2025), $5.0 million (Q2 2025), and $5.4 million (Q1 2025).